Patents by Inventor Volker Briken

Volker Briken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124476
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Application
    Filed: December 26, 2023
    Publication date: April 18, 2024
    Inventors: Lyle David Isaacs, Volker Briken, Gaya Hettiarachchi, Da Ma, Duc M. Nguyen
  • Patent number: 11897893
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: February 13, 2024
    Assignee: University of Maryland, College Park
    Inventors: Lyle David Isaacs, Volker Briken, Gaya Hettiarachchi, Da Ma, Duc M. Nguyen
  • Publication number: 20210206774
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Application
    Filed: December 14, 2020
    Publication date: July 8, 2021
    Inventors: Lyle David Isaacs, Volker Briken, Gaya Hettiarachchi, Da Ma, Duc M. Nguyen
  • Publication number: 20170137431
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Application
    Filed: January 27, 2017
    Publication date: May 18, 2017
    Inventors: Lyle David Isaacs, Volker Briken, Gaya Hettiarachchi, Da Ma, Duc M. Nguyen
  • Patent number: 9567344
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: February 14, 2017
    Assignee: University of Maryland, College Park
    Inventors: Lyle David Isaacs, Volker Briken, Da Ma, Gaya Hettiarachchi, Duc M. Nguyen
  • Patent number: 9566351
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: February 14, 2017
    Assignee: University of Maryland, College Park
    Inventors: Volker Briken, Lyle David Isaacs, Gaya Hettiarachchi, Ben Zhang
  • Publication number: 20150328334
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Application
    Filed: June 9, 2015
    Publication date: November 19, 2015
    Inventors: Volker Briken, Lyle David Isaacs, Gaya Hettiarachchi, Ben Zhang
  • Publication number: 20140094529
    Abstract: Acyclic CB[n]-type compounds, methods of making such compounds, and uses of the compounds. For example, these compounds can be used as nanocontainers to solubilize pharmaceutical agents. Also provided are compositions and methods of using them for therapy or prophylaxis of a wide variety of conditions for which therapy or prophylaxis is desirable.
    Type: Application
    Filed: October 13, 2011
    Publication date: April 3, 2014
    Applicant: UNIVERSITY OF MARYLAND, COLLEGE PARK
    Inventors: Lyle David Isaacs, Volker Briken, Gaya Hettiarachchi, Da Ma, Duc M. Nguyen
  • Patent number: 8394388
    Abstract: Provided are recombinant mycobacteria having a mutation in an nlaA gene or in a nuoG gene. Also provided are isolated and purified nlaA proteins and nuoG proteins from a mycobacterium. Additionally provided are isolated and purified nucleic acids comprising a recombinant nlaA gene or a recombinant nuoG gene. Further provided are methods of inducing an immune response in a mammal and methods of making a recombinant mycobacterium using the nlaA gene or the nuoG gene.
    Type: Grant
    Filed: January 12, 2006
    Date of Patent: March 12, 2013
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: William R. Jacobs, Jr., Steven A. Porcelli, Volker Briken, Miriam Braunstein
  • Publication number: 20100297185
    Abstract: Provided are recombinant mycobacteria having a mutation in an nlaA gene or in a nuoG gene. Also provided are isolated and purified nlaA proteins and nuoG proteins from a mycobacterium. Additionally provided are isolated and purified nucleic acids comprising a recombinant nlaA gene or a recombinant nuoG gene. Further provided are methods of inducing an immune response in a mammal and methods of making a recombinant mycobacterium using the nlaA gene or the nuoG gene.
    Type: Application
    Filed: January 12, 2006
    Publication date: November 25, 2010
    Inventors: William R. Jacobs, JR., Steven A. Porcelli, Volker Briken, Miriam Braunstein